• MASTER-2 (Relapsing MS Trial)

Cladribine Tablets: Observational Evaluation of Effectiveness and Patient-Reported Outcomes (PROs) in Suboptimally Controlled Patients Previously Taking Oral or Infusion Disease-Modifying Drugs (DMDs) for Relapsing Forms of Multiple Sclerosis (RMS

If you would like additional information regarding this trial please contact researchopportunities@prairieresearch.com

https://www.clinicaltrials.gov/ct2/show/NCT03933202

 

  • CLICK-MS (Relapsing MS Trial)

Cladribine Tablets: Observational Evaluation of Effectiveness and Patient-Reported Outcomes (PROs) in Suboptimally Controlled Patients Previously Taking Injectable Disease-Modifying Drugs (DMDs) for Relapsing Forms of Multiple Sclerosis (RMS)

If you would like additional information regarding this trial please contact researchopportunities@prairieresearch.com

https://www.clinicaltrials.gov/ct2/show/NCT03933215